Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin‐containing regimens

Publisher： John Wiley & Sons Inc

E-ISSN： 1523-5378|23|1|hel.12452-hel.12452

ISSN： 1083-4389

Source： Helicobacter (Electronic), Vol.23, Iss.1, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors associated with virological success with raltegravir-containing regimens and prevalence of raltegravir-resistance-associated mutations at failure in the ARCA database

By Rusconi S.   Vitiello P.   Adorni F.   Bruzzone B.   Luca A.   Micheli V.   Meraviglia P.   Maserati R.   Di Pietro M.   Colao G.   Penco G.   Di Biagio A.   Punzi G.   Monno L.   Zazzi M.     Antonelli G.  

Clinical Microbiology & Infection, Vol. 19, Iss. 10, 2013-10 ,pp. : 936-942

Blackwell Publishing

Access to resources Recommend Favorite

Comparison Between 10‐ and 14‐Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial

By  

Helicobacter (Electronic), Vol. 20, Iss. 4, 2015-08 ,pp. : 299-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

Helicobacter pylori and Nonmalignant Diseases

By  

Helicobacter (Electronic), Vol. 20, Iss. S1, 2015-09 ,pp. : 26-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extragastric Diseases and Helicobacter pylori

By  

Helicobacter (Electronic), Vol. 20, Iss. S1, 2015-09 ,pp. : 40-46

John Wiley & Sons Inc

Access to resources Recommend Favorite

Helicobacter pylori and Gastrointestinal Malignancies

By  

Helicobacter (Electronic), Vol. 20, Iss. S1, 2015-09 ,pp. : 36-39

John Wiley & Sons Inc

Access to resources Recommend Favorite